CD19 CAR T cell product and disease attributes predict leukemia remission durabilityOlivia Finney, Michael C. Jensen|Journal of Clinical Investigation|2019Cited by 345
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S.W. Borgers, Marit M. van Buuren, Victoria Kohler et al.|Nature Medicine|2025Cited by 40